UiPath (NYSE:PATH) Rating Reiterated by Truist Financial

UiPath (NYSE:PATH – Get Free Report)‘s stock had its “hold” rating reaffirmed by Truist Financial in a report issued on Thursday, MarketBeat.com reports. They presently have a $14.00 target price on the healthcare company’s stock, down from their previous target price of $32.00. Truist Financial’s target price would indicate a potential upside of 14.19% from […]

Related Keywords

United States ,Romania ,United Kingdom ,Canada ,Netherlands ,Ashim Gupta ,Highmark Wealth Management ,Securities Exchange Commission ,Barclays ,Mark Sheptoff Financial Planning ,Cypress Capital Management ,Keycorp ,Royal Bank ,Uipath Inc ,Uipath Company Profile ,Get Free Report ,Truist Financial ,Exchange Commission ,Sheptoff Financial Planning ,Mark Wealth Management ,Capital Management ,Path Inc ,Uipath Daily ,